Open Government Portal

Found 2972 records

Health Canada's drug products fact sheet describes how drugs are reviewed in Canada including how drugs are developed and submitted …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Drug review priority review fast-track life-saving drugs expedited and authorization for clinical trial.

How to access a list of generic drug submissions currently under review.

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Drug submission generic submissions under review drug and health product review and approval.

For eligible submissions accepted into review on or after October 1, 2018, the submission 'class' added to the Lists of …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Submission class submissions under review drug and health product review and approval.

Present the list of new drug submissions (NDSs) that are currently being reviewed.

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Drug submission submissions under review drug and health product review and approval.

Understand the decisions to approve or not approve the sale of drugs and medical devices in Canada.

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Regulatory decision drug and health product review and approval sale of drugs and medical devices.

Drug shortages can occur for any number of reasons and can result from problems at any point in the drug …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Drug Drug supply chain causes of Drug Shortages.

The Canadian drug supply chain is complex, with distinct roles and responsibilities among many players including manufacturers, wholesalers, hospitals, health …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Drug Supply Chain distinct roles and responsibilities manufacturers wholesalers hospitals health care practitioners and governments.

This notice explains under which circumstances non-medical masks or face coverings would be subject to the regulatory framework for medical …

Record Modified: Aug 28, 2020
Record Released: Aug 28, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic Notice to industry regulatory framework for medical devices non-medical masks face coverings.

All Canadian drug establishments must have a drug establishment licence to fabricate, package/label, distribute, import, wholesale or test a drug …

Record Modified: Aug 28, 2020
Record Released: Aug 28, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic Drug establishment licences Part C Division 1A of the Food and Drug Regulations.

Good manufacturing practices (GMP) ensure that drugs meet the quality standards appropriate to their intended use before they are sold.

Record Modified: Aug 28, 2020
Record Released: Aug 28, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic Good Manufacturing Practices quality standards.